Biomed Hitech Industries Limited - Company Profile

It is a financial services public limited company based in Chennai-119., Tamil Nadu, India, established in 1992.
1992 Chennai-119., Tamil Nadu, India Active
Last Updated:
Access Report
About Biomed Hitech Industries Limited

Biomed Hitech Industries Limited, a active public limited company, was established on 01 September 1992 in Chennai-119., Tamil Nadu, India. Engaging in real estate financing within the real estate sector, it holds CIN: U70200TN1992PLC023371. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹4.74 Cr.

Formerly known as Biomedical Products Madras Pvt Ltd. It upholds a compliant status. Its leadership includes Chellappan Tamil Selvan (Director), Vijayakumar Palaniswami Mathura (Director), Nallagounder Palaniswami (Managing Director). Past directors included Chellappan Tamil Selvan, Vijayakumar Palaniswami Mathura, Deivasigamani Palaniswamy. It holds no open charges and ₹33.09 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 475/Part, Old Mahabalipuram Road Sholinganallur, Chennai-119., Tamil Nadu, 600119.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U70200TN1992PLC023371

  • Registration Number

    023371

  • Incorporation Date

    01 September 1992

  • Authorized Capital

    ₹20.00 Cr

  • Paid-Up Capital

    ₹4.74 Cr

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 20.00 Cr
  • Paid Up Capital ₹ 4.74 Cr
  • Company Age 33 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 33.09 Cr
  • Revenue Growth **** -2.03%
  • Profit Growth **** -177.56%
  • Ebitda **** 0.78%
  • Net Worth -7.66%
  • Total Assets -12.10%
Company report

Biomed Hitech Industries Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Biomed Hitech Industries Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Biomed Hitech Industries Limited?
Current Directors
Name Designation Appointment Date Status
Chellappan Tamil Selvan Director 20 Feb 2023 Current
Vijayakumar Palaniswami Mathura Director 10 Feb 2023 Current
Nallagounder Palaniswami Managing Director 30 Sep 1998 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 27 Feb 2018 Past
Pramod Abcsdd Additional Director 29 Sep 2023 Past
Pramod Abcsdd Director 20 Feb 2023 Past
Pramod Abcsdd Director 26 Jun 2011 Past
Pramod Abcsdd Director 28 Sep 2012 Past
Pramod Abcsdd Director 11 May 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Biomed Hitech Industries.

Biomed Hitech Industries Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 2.03% decrease. The company also saw a substantial fall in profitability, with a 177.56% decrease in profit. The company's net worth dipped by a decrease of 7.66%.

Biomed Hitech Industries revenue growth over time
Biomed Hitech Industries profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -2.03%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -12.10%
*******
*******
*******
*******
Profit or Loss
*******
 -177.56%
*******
*******
*******
*******
Net Worth
*******
 -7.66%
*******
*******
*******
*******
EBITDA
*******
 0.78%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Biomed Hitech Industries?

In 2022, Biomed Hitech Industries had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹330,900,000.00

Charges Breakdown by Lending Institutions
  • Bharat Overseas Bank Ltd. : 13.80 Cr
  • Ind. Reconstruction Bank Of India : 5.00 Cr
  • Idbi : 3.40 Cr
  • Ind; Development Bank Of India : 2.19 Cr
  • Bharat Overseas Bank Ltd : 2.00 Cr
  • Others : 6.70 Cr
Latest Charge Details
Date Lender Amount Status
29 Mar 1999 Ind. Investment Bank Of India Ltd. ₹2.00 Cr Satisfied
24 Mar 1999 Idbi ₹3.40 Cr Satisfied
22 Mar 1999 Icici Ltd. ₹1.20 Cr Satisfied
20 May 1998 Bharat Overseas Bank Ltd ₹2.00 Cr Satisfied
26 Mar 1998 Bharat Overseas Bank Ltd. ₹13.80 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Biomed Hitech Industries?

Unlock and access historical data on people associated with Biomed Hitech Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Biomed Hitech Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biomed Hitech Industries's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Biomed Hitech Industries
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Biomed Hitech Industries Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Biomed Hitech Industries Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was documented.

  • Director Appointment

    Chellappan Tamil Selvan was appointed as a Director was appointed as a Director on 20 Feb 2023 & has been associated with this company since 3 years 1 month . was recorded as a recent event.

  • Director Appointment

    The activity Vijayakumar Palaniswami Mathura was appointed as a Director was appointed as a Director on 10 Feb 2023 & has been associated with this company since 3 years 1 month . was completed.

  • Charges

    A charge registered on 20 May 1998 via Charge ID 90285205 with Bharat Overseas Bank Ltd was fully satisfied on 31 Mar 2007. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 26 Mar 1998 via Charge ID 90286784 with Bharat Overseas Bank Ltd. was fully satisfied on 31 Mar 2007. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Biomed Hitech Industries Limited?

The CIN of Biomed Hitech Industries Limited is U70200TN1992PLC023371.

Where is Biomed Hitech Industries Limited headquartered?

Biomed Hitech Industries Limited is headquartered at 475/Part, Old Mahabalipuram Road Sholinganallur, Chennai-119., Tamil Nadu, 600119.

When was Biomed Hitech Industries Limited incorporated?

Biomed Hitech Industries Limited was incorporated on 01 September 1992.

Who are the current directors of Biomed Hitech Industries Limited?

The current directors of Biomed Hitech Industries Limited are

What is the primary industry of Biomed Hitech Industries Limited?

The primary industry of Biomed Hitech Industries Limited is Real Estate.

Is Biomed Hitech Industries Limited a listed company?

Biomed Hitech Industries Limited is unlisted.

What is the capital structure of Biomed Hitech Industries Limited?

The authorized capital of Biomed Hitech Industries Limited is ₹20.00 Cr, and the paid-up capital is ₹4.74 Cr.

What is the compliance status of Biomed Hitech Industries Limited?

The compliance status of Biomed Hitech Industries Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available